Capricor Therapeutics (CAPR) Shares Issued (2011 - 2024)

Capricor Therapeutics' Shares Issued history runs 10 years deep, the most recent figure standing at $59850.0 for Q4 2024.

• On a quarterly basis, Shares Issued fell 99.27% year-over-year to $59850.0 in Q4 2024; TTM through Dec 2024 was $59850.0, a 99.27% decrease from a year earlier, with the FY2024 full-year figure at $59850.0, down 99.27% from the prior year.
• Shares Issued fell to $59850.0 in Q4 2024 per CAPR's latest filing, from $458869.0 in the prior quarter.
• Across five years, Shares Issued topped out at $10.6 million in Q1 2024 and bottomed at $59850.0 in Q4 2024.
• The 5-year median for Shares Issued is $1.9 million (2022), against an average of $2.8 million.
• Biggest YoY gain for Shares Issued was 505.05% in 2024; the steepest drop was 99.27% in 2024.
• Year by year, Shares Issued stood at $2.4 million in 2020, then jumped by 60.63% to $3.8 million in 2021, then jumped by 52.27% to $5.8 million in 2022, then surged by 42.51% to $8.2 million in 2023, then slumped by 99.27% to $59850.0 in 2024.
• Per Business Quant, the three latest CAPR Shares Issued figures stand at $59850.0 (Q4 2024), $458869.0 (Q3 2024), and $357625.0 (Q2 2024).